Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds

被引：25

作者：

Schmitz, FJ

Krey, A

Geisel, R

Verhoef, J

Heinz, HP

Fluit, AC

机构：

[1] Univ Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany

[2] Univ Utrecht, Eijkman Winkler Inst Clin Microbiol, Utrecht, Netherlands

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1999年 / 18卷 / 07期

关键词：

D O I：

10.1007/s100960050340

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：528 / 530

页数：3

共 15 条

[1] INVITRO ANTISTAPHYLOCOCCAL ACTIVITY AND TESTING OF RP-59500, A NEW STREPTOGRAMIN, BY 2 METHODS [J].

ALDRIDGE, KE ;

SCHIRO, DD ;

VARNER, LM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :854-855

[2]

*CDCP, 1997, MORBIDITY MORTALITY, V46, P2064

[3]

Chambers HF, 1997, STAPHYLOCOCCI HUMAN, P583

[4] Interpretive criteria for testing susceptibility of staphylococci to mupirocin [J].

Finlay, JE ;

Miller, LA ;

Poupard, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1137-1139

[5] Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].

Hanaki, H ;

Kuwahara-Arai, K ;

Boyle-Vavra, S ;

Daum, RS ;

Labischinski, H ;

Hiramatsu, K .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209

[6] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].

Hiramatsu, K ;

Aritaka, N ;

Hanaki, H ;

Kawasaki, S ;

Hosoda, Y ;

Hori, S ;

Fukuchi, Y ;

Kobayashi, I .

LANCET, 1997, 350 (9092) :1670-1673

[7] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

[8] In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis [J].

Kaatz, GW ;

Seo, SM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :799-801

[9]

National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS

[10] Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme [J].

Schmitz, FJ ;

Verhoef, J ;

Fluit, AC .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) :414-421

← 1 2 →